Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Nurix Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 170 | 164 | −6 |
| Shares | 84.6M | 88.3M | +3.72M (+4.4%) |
| Value | $1.01B | $1.01B | +$824.6K (+0.1%) |
New holders (24)
Institutions that held Nurix Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (30)
Institutions that held Nurix Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.